报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2025-03-31 | 1.65% | 68.37% | -57.14% | 65/159 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
2024-12-31 | 3.85% | 97.44% | 55.87% | 67/159 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
2024-09-30 | 2.47% | 1.65% | 15.42% | 94/159 | 4.18% | 百利天恒 | 186.1% | 行业排名> |
2024-06-30 | 2.14% | 75.41% | 118.37% | 79/159 | 2.63% | 百利天恒 | 186.89% | 行业排名> |
2024-03-31 | 0.98% | 24.05% | -49.74% | 95/159 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
2023-12-31 | 1.95% | -87.42% | -19.75% | 89/159 | -1.03% | 小方制药 | 41.8% | 行业排名> |
2023-09-30 | 2.43% | -86.22% | 99.18% | 99/159 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
2023-06-30 | 1.22% | -86.77% | 54.43% | 99/159 | 1.47% | 拓新药业 | 19.87% | 行业排名> |
2023-03-31 | 0.79% | -86.09% | -94.9% | 100/159 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
2022-12-31 | 15.5% | -28.96% | -12.13% | 18/159 | 0.74% | 小方制药 | 55.57% | 行业排名> |
2022-09-30 | 17.64% | 7.1% | 91.32% | 5/159 | 2.89% | 福元医药 | 25.41% | 行业排名> |
2022-06-30 | 9.22% | -12.94% | 62.32% | 15/159 | 2.22% | 小方制药 | 34.81% | 行业排名> |
2022-03-31 | 5.68% | 53.1% | -73.97% | 10/159 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
2021-12-31 | 21.82% | 70.87% | 32.48% | 9/159 | 0.87% | 人福医药 | 6.82% | 行业排名> |
2021-09-30 | 16.47% | 130.35% | 55.52% | 10/159 | 4.53% | 小方制药 | 71.99% | 行业排名> |
2021-06-30 | 10.59% | 2% | 185.44% | 14/159 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
2021-03-31 | 3.71% | 827.5% | -70.95% | 29/159 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
2020-12-31 | 12.77% | 55.35% | 78.6% | 39/159 | 3.71% | 哈三联 | 27.17% | 行业排名> |
2020-09-30 | 7.15% | 2% | 1687.5% | 57/159 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
2020-03-31 | 0.4% | 2% | -95.13% | 77/159 | 2.24% | 河化股份 | 45.32% | 行业排名> |
2019-12-31 | 8.22% | 0.61% | 0.61% | 69/159 | 2.71% | 汇宇制药 | 31.9% | 行业排名> |
2018-12-31 | 8.17% | -46.32% | -46.32% | 64/159 | 7.09% | 誉衡药业 | 35.56% | 行业排名> |
2017-12-31 | 15.22% | 2% | 2% | 24/159 | 9.66% | 奥赛康 | 35% | 行业排名> |